FDA recall D-0454-2024

Product

libigrow RED DRAGON+, Maximum Strength Formula, 2 capsules per box, UPC 7 05105 83073 5.

Reason for recall

Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.

Distribution

Nationwide in the USA

Key facts

Status

Ongoing

Initiation date

2024-03-19

Report date

2024-05-01

Voluntary/Mandated

Voluntary: Firm initiated

Location

Los Angeles, CA, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0454-2024